Health ❯ Healthcare ❯ Clinical Trials

Phase Studies

Tinlarebant Rilzabrutinib Phase II Trials Phase 2/3 Study Phase-Three Trials Cardiovascular Diseases GO29781 Trial DEVOTE Study GO29781 Study LUMINA Studies Lupus Research

FDA Grants Breakthrough Therapy Designation to Biogen’s Litifilimab for Cutaneous Lupus

The status reflects Phase 2 evidence of reduced skin disease activity in patients with cutaneous lupus erythematosus.

FDA Grants Accelerated Approval to Subcutaneous Lunsumio for Relapsed Follicular Lymphoma

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

EMA Panel Backs Higher-Dose Spinraza for 5q SMA

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials